The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
so we are supposed to accept it without validation from other parties, just because company says The breakthrough data
"" 12 yrs since I left! "" said Mark Barry, founded and set up Q Chip.
but
no pruduct in market or pIII-IV
"" Company expects to initiate a Phase II study in DIPG later this year ""
who will fund this
have they enough panobinostat supply untill becoming a generic in 2025
* issue price of £0.27 per Unit
discount of approximately 35% to the closing middle market price of £0.415 per existing ordinary share on 15 May 2020
* issue price of £0.27 per share
a discount of approximately 32% to the closing middle market price of £0.395 per existing ordinary share on 24 July 2020
unless partner sign a licence deal before 4th Q
raise will be here
as said by some, Viveka`s expertise in drug delivery kept me interesting in mtph,
unfortunately not posting anymore ( think , lost interest in company)
instead of buyers,
they got partners / Collaboration
also almost all holders ( shares & warrants ... ) had to declare
RNS Number : 8199T
23 July 2020
Corporate Update & Formal Sale Process Termination
some people avoiding to mention it, will be before the fourth quarter of 2021
At least one II selling & warrants exercised + RNS 2737X
imho
Armistice Capital LLC 1.53% 0.78% 17 Jun 2021
https://shorttracker.co.uk/company/GB00BKT14T00/
CAR3Y Premium Member
Posted in: MTPH
Posts: 1,057
Price: 43.50
No Opinion
RE: Value17 Jun 2021 10:12
Na ain’t block buys, it’s me exercising warrants! Dyor
17.06.2021
short position in Midatech Pharma Plc (MTPH)
still @ 0.75% no change from 12 Mar 2021
https://shorttracker.co.uk/company/GB00BKT14T00/
should have been "" Grid Players ""
correlation is the Drid Players in LSE & USA working in harmony
imho
he`s gone for option:
" Buy Now Pay Later "
imo
nothing,
unless your one of them
Capital raise in the pipeline?
thats what i think
ramp up SP before the AGM
so, what it going to be on this webinar that can not be put on The regulatory news service (RNS) making it official?
Dr Andrew Hill PhD analysis
https://www.medrxiv.org/content/10.1101/2021.06.01.21258147v1.full.pdf
&
The COVID-19 Therapeutics Taskforce
https://www.gov.uk/government/groups/the-covid-19-therapeutics-taskforce
why not get OILEX on a major tabloid paper first
it will help SP as well
Mikep109
Oakleaf72
:)
ask him why he did not chose to include any type of INF in the analysis
Corresponding author:
Dr Andrew Hill PhD
Department of Pharmacology and Therapeutics
University of Liverpool,
70 Pembroke Place
Liverpool L69 3GF, UK
Email: microhaart@aol.com
think,
lot of you knew this report Posted June 03, 2021
but kept quite
Tested my newly purchased Grippferon and its active in HEK-Blue cells! Excellent results.
Senior Scientist at Novici Biotech
https://twitter.com/KasPadgett/status/1369536482726141952
Grippferon @ €10
https://rupharma.com/grippferon-interferon-alfa-2b/
Laferobion @ $30.90
http://mukundastore.com/index.php?route=product/product&product_id=5060
geneticist Alexandra Herion-Caude
https://rumble.com/vi0md7-alexandra-herion-caude-full-interview-inside-planet-lockdown.html
Something remarkable might be about to happen.
https://twitter.com/Covid19Crusher/status/1401479066268717058
Crusher - it’s already happened
https://twitter.com/CraigKellyMP/status/1401508122632482822